CN107232186A - 一种人脂肪干细胞用的细胞冻存液 - Google Patents
一种人脂肪干细胞用的细胞冻存液 Download PDFInfo
- Publication number
- CN107232186A CN107232186A CN201710643072.1A CN201710643072A CN107232186A CN 107232186 A CN107232186 A CN 107232186A CN 201710643072 A CN201710643072 A CN 201710643072A CN 107232186 A CN107232186 A CN 107232186A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- polypeptide
- human adipose
- derived stem
- stock solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 78
- 210000004027 cell Anatomy 0.000 title claims abstract description 45
- 239000007788 liquid Substances 0.000 title abstract description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 82
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 79
- 229920001184 polypeptide Polymers 0.000 claims abstract description 78
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 72
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 72
- 239000011550 stock solution Substances 0.000 claims abstract description 52
- 238000002360 preparation method Methods 0.000 claims abstract description 39
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 37
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 37
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 37
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 36
- 108010024636 Glutathione Proteins 0.000 claims abstract description 36
- 102000007330 LDL Lipoproteins Human genes 0.000 claims abstract description 36
- 108010007622 LDL Lipoproteins Proteins 0.000 claims abstract description 36
- 229960003180 glutathione Drugs 0.000 claims abstract description 36
- 235000011187 glycerol Nutrition 0.000 claims abstract description 36
- 235000010445 lecithin Nutrition 0.000 claims abstract description 36
- 229940067606 lecithin Drugs 0.000 claims abstract description 36
- 239000000787 lecithin Substances 0.000 claims abstract description 36
- 230000002829 reductive effect Effects 0.000 claims abstract description 36
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims abstract description 35
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 35
- 238000011084 recovery Methods 0.000 claims abstract description 6
- 230000004083 survival effect Effects 0.000 claims abstract description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 39
- 238000002156 mixing Methods 0.000 claims description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 72
- 229930003427 Vitamin E Natural products 0.000 abstract description 36
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 36
- 229940046009 vitamin E Drugs 0.000 abstract description 36
- 235000019165 vitamin E Nutrition 0.000 abstract description 36
- 239000011709 vitamin E Substances 0.000 abstract description 36
- 239000000243 solution Substances 0.000 description 15
- 238000005138 cryopreservation Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 102100037241 Endoglin Human genes 0.000 description 2
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 230000002293 adipogenic effect Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100022002 CD59 glycoprotein Human genes 0.000 description 1
- 230000035519 G0 Phase Effects 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 230000004668 G2/M phase Effects 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
- 101000994369 Homo sapiens Integrin alpha-5 Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 102100032817 Integrin alpha-5 Human genes 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- -1 bFGF1%w/ V Chemical compound 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dentistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710643072.1A CN107232186B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710643072.1A CN107232186B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201610124499.6A CN105494317B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610124499.6A Division CN105494317B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107232186A true CN107232186A (zh) | 2017-10-10 |
CN107232186B CN107232186B (zh) | 2018-09-21 |
Family
ID=55702932
Family Applications (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610124499.6A Active CN105494317B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470134.8A Pending CN109090097A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470472.1A Pending CN108633876A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470080.5A Pending CN108541700A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470079.2A Pending CN108633875A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201710643072.1A Expired - Fee Related CN107232186B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470473.6A Pending CN108541701A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470133.3A Pending CN108450460A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470135.2A Pending CN108617639A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470078.8A Pending CN108450459A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610124499.6A Active CN105494317B (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470134.8A Pending CN109090097A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470472.1A Pending CN108633876A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470080.5A Pending CN108541700A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470079.2A Pending CN108633875A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810470473.6A Pending CN108541701A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470133.3A Pending CN108450460A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470135.2A Pending CN108617639A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
CN201810470078.8A Pending CN108450459A (zh) | 2016-03-06 | 2016-03-06 | 一种人脂肪干细胞用的细胞冻存液 |
Country Status (1)
Country | Link |
---|---|
CN (10) | CN105494317B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108378019A (zh) * | 2018-03-13 | 2018-08-10 | 洛阳轩智生物科技有限公司 | 一种人精原干细胞的冻存液 |
CN109938010A (zh) * | 2019-03-20 | 2019-06-28 | 江苏瑞思坦生物科技有限公司 | 一种人脂肪间充质干细胞运输液及其制备方法 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107183008A (zh) * | 2017-05-27 | 2017-09-22 | 魏方萌 | 一种胎盘间充质干细胞冻存液及其冻存方法 |
CN107027743B (zh) * | 2017-06-14 | 2020-12-29 | 沃昕生物科技(深圳)有限公司 | 细胞冻存液及细胞冻存方法 |
CN107156111A (zh) * | 2017-06-30 | 2017-09-15 | 陈印平 | 一种造血干细胞细胞冻存剂 |
CN107232182A (zh) * | 2017-06-30 | 2017-10-10 | 陈印平 | 一种骨髓间充质干细胞细胞冻存剂 |
CN110547286B (zh) * | 2018-06-01 | 2021-08-20 | 梵美国际再生医学科技有限公司 | 复合冻存液及其制备方法和应用 |
CN112143696B (zh) * | 2018-10-10 | 2022-06-14 | 浙江神雁精准医疗科技有限公司 | 包含干细胞活性物质组合物的试剂盒及其制备方法 |
CN109430246A (zh) * | 2018-11-21 | 2019-03-08 | 天津医科大学 | 一种无血清干细胞冻存液及干细胞冻存方法 |
CN109362712A (zh) * | 2018-11-29 | 2019-02-22 | 广州润虹医药科技股份有限公司 | 一种脂肪组织冻存液、冻存方法及其应用 |
CN109430252A (zh) * | 2018-12-25 | 2019-03-08 | 成都赋智健康科技有限公司 | 一种干细胞冻存液及其制作方法 |
CN109662091B (zh) * | 2019-03-01 | 2021-04-13 | 米楠 | 一种脂肪颗粒组织冻存液及其配制方法和冻存方法 |
CN109845728B (zh) * | 2019-03-25 | 2021-07-23 | 西安医斯美生物科技有限公司 | 临床应用级别的脂肪组织冻存液及冻存方法 |
CN110786320A (zh) * | 2019-11-28 | 2020-02-14 | 郑州市和沐生物科技有限公司 | 一种脂肪组织冻存液及其配置方法 |
CN112075418B (zh) * | 2020-09-29 | 2021-10-22 | 惟力维斯(上海)医学科技有限公司 | 脂肪间充质干细胞冻存液以及脂肪间充质干细胞冻存方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1822850A (zh) * | 2003-07-18 | 2006-08-23 | 雷根内克斯生物制药有限公司 | 由放射线照射引起的损伤的治疗或预防 |
CN102550542A (zh) * | 2011-08-09 | 2012-07-11 | 臻景生物技术(上海)有限公司 | 用于脂肪干细胞的无血清冻存液及脂肪干细胞库的建立 |
CN102732477A (zh) * | 2012-06-15 | 2012-10-17 | 江苏瑞思坦生物科技有限公司 | 人脂肪干细胞无血清基础培养基 |
CN103243070A (zh) * | 2013-04-25 | 2013-08-14 | 刘小青 | 一种干细胞培养基及其应用 |
CN105076116A (zh) * | 2015-09-17 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种细胞冻存液及其应用与巨核祖细胞的冻存方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1181865A1 (en) * | 2000-08-23 | 2002-02-27 | Universite Catholique De Louvain | Cryoprotective solutions |
EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
CN102246745B (zh) * | 2011-05-16 | 2014-04-16 | 西北农林科技大学 | 用于动物精原干细胞冷冻保存的抗冻剂及其方法 |
CN102907416B (zh) * | 2012-08-01 | 2016-08-03 | 西比曼生物科技(上海)有限公司 | 一种可维持细胞活性的组织冻存液 |
CN104012519B (zh) * | 2013-02-28 | 2015-11-18 | 杭州启迪生物科技有限公司 | 一种脂肪干细胞-生物材料复合物冻存液及其用途 |
KR101668743B1 (ko) * | 2014-08-08 | 2016-10-25 | (주)세포바이오 | 식물 유래 재조합 인간 혈청 알부민 및 식물성 펩타이드를 유효성분으로 함유하는 세포 보존용 조성물 |
CN104164405A (zh) * | 2014-08-12 | 2014-11-26 | 赛业(苏州)生物科技有限公司 | 一种高效的体外培养人脐带间质干细胞的无血清培养体系 |
CN104472474A (zh) * | 2014-11-21 | 2015-04-01 | 广州赛莱拉干细胞科技股份有限公司 | 一种人脂肪间充质干细胞冻存液 |
CN105087462A (zh) * | 2015-07-24 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | 干细胞冻存液及干细胞冻存方法 |
-
2016
- 2016-03-06 CN CN201610124499.6A patent/CN105494317B/zh active Active
- 2016-03-06 CN CN201810470134.8A patent/CN109090097A/zh active Pending
- 2016-03-06 CN CN201810470472.1A patent/CN108633876A/zh active Pending
- 2016-03-06 CN CN201810470080.5A patent/CN108541700A/zh active Pending
- 2016-03-06 CN CN201810470079.2A patent/CN108633875A/zh active Pending
- 2016-03-06 CN CN201710643072.1A patent/CN107232186B/zh not_active Expired - Fee Related
- 2016-03-06 CN CN201810470473.6A patent/CN108541701A/zh active Pending
- 2016-03-06 CN CN201810470133.3A patent/CN108450460A/zh active Pending
- 2016-03-06 CN CN201810470135.2A patent/CN108617639A/zh active Pending
- 2016-03-06 CN CN201810470078.8A patent/CN108450459A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1822850A (zh) * | 2003-07-18 | 2006-08-23 | 雷根内克斯生物制药有限公司 | 由放射线照射引起的损伤的治疗或预防 |
CN102550542A (zh) * | 2011-08-09 | 2012-07-11 | 臻景生物技术(上海)有限公司 | 用于脂肪干细胞的无血清冻存液及脂肪干细胞库的建立 |
CN102732477A (zh) * | 2012-06-15 | 2012-10-17 | 江苏瑞思坦生物科技有限公司 | 人脂肪干细胞无血清基础培养基 |
CN103243070A (zh) * | 2013-04-25 | 2013-08-14 | 刘小青 | 一种干细胞培养基及其应用 |
CN105076116A (zh) * | 2015-09-17 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种细胞冻存液及其应用与巨核祖细胞的冻存方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108378019A (zh) * | 2018-03-13 | 2018-08-10 | 洛阳轩智生物科技有限公司 | 一种人精原干细胞的冻存液 |
CN108378019B (zh) * | 2018-03-13 | 2021-03-02 | 诺赛联合(北京)生物医学科技有限公司 | 一种人精原干细胞的冻存液 |
CN109938010A (zh) * | 2019-03-20 | 2019-06-28 | 江苏瑞思坦生物科技有限公司 | 一种人脂肪间充质干细胞运输液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107232186B (zh) | 2018-09-21 |
CN108617639A (zh) | 2018-10-09 |
CN105494317A (zh) | 2016-04-20 |
CN108450460A (zh) | 2018-08-28 |
CN108450459A (zh) | 2018-08-28 |
CN108541700A (zh) | 2018-09-18 |
CN105494317B (zh) | 2017-09-29 |
CN108633876A (zh) | 2018-10-12 |
CN108633875A (zh) | 2018-10-12 |
CN109090097A (zh) | 2018-12-28 |
CN108541701A (zh) | 2018-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105494317B (zh) | 一种人脂肪干细胞用的细胞冻存液 | |
CN105586311B (zh) | 一种用于培养人脂肪干细胞的培养基 | |
CN105432599B (zh) | 一种白血病治疗用的细胞冻存液 | |
CN105394029B (zh) | 一种用于白血病治疗的细胞冻存液 | |
CN108057014A (zh) | 一种美容护肤的干细胞制剂的制备方法 | |
Zhan et al. | The reparative effects of human adipose-derived mesenchymal stem cells in the chemotherapy-damaged thymus | |
CN107232182A (zh) | 一种骨髓间充质干细胞细胞冻存剂 | |
CN113558042A (zh) | 一种外泌体的保存方法 | |
CN106834217A (zh) | 一种促进人羊膜上皮细胞体外扩增的方法及应用 | |
Zhang et al. | Effects of RPE‑conditioned medium on the differentiation of hADSCs into RPE cells, and their proliferation and migration | |
JPS62278979A (ja) | 動物細胞の培養方法 | |
Alchinova et al. | The Size of Vesicles Produced By Different Stem Cells | |
Bodeus et al. | In Vitro Production of Rat Monoclonal Antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180810 Address after: 450000 Zhengzhou District, Henan 27 District, north of Mid Autumn Road, Beijing Guangzhou Road West, Nanxi Road East commercial housing four floors 301-311 rooms. Applicant after: Zhengzhou Ou fan Medical Equipment Co., Ltd. Address before: 215137 Soochow University, 8 Xiangcheng District Ji Xue Road, Suzhou, Jiangsu Applicant before: Li Qian |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180921 Termination date: 20190306 |